Showing 1 - 6 results of 6 for search 'Karin Lövgren Bengtsson', query time: 0.03s Refine Results
  1. 1
    Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs

    Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs by Viktor Ahlberg, Bernt Hjertner, Per Wallgren, Stina Hellman, Karin Lövgren Bengtsson, Caroline Fossum

    Published 2017-05-01
    Get full text
    Article
  2. 2
    Matrix-M™ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen.

    Matrix-M™ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen. by Jenny M Reimer, Karin H Karlsson, Karin Lövgren-Bengtsson, Sofia E Magnusson, Alexis Fuentes, Linda Stertman

    Published 2012-01-01
    Get full text
    Article
  3. 3
    The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century

    The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century by Linda Stertman, Anna-Karin E. Palm, Behdad Zarnegar, Berit Carow, Carolina Lunderius Andersson, Sofia E. Magnusson, Cecilia Carnrot, Vivek Shinde, Gale Smith, Gregory Glenn, Louis Fries, Karin Lövgren Bengtsson

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine

    Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine by Susheel K. Singh, Jordan Plieskatt, Bishwanath K. Chourasia, Vandana Singh, Karin Lövgren Bengtsson, Jenny M. Reimer, Renate C. van Daalen, Karina Teelen, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Matthijs M. Jore, Michael Theisen

    Published 2021-10-01
    Get full text
    Article
  5. 5
    A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine

    A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine by Susheel K. Singh, Susheel K. Singh, Jordan Plieskatt, Bishwanath K. Chourasia, Bishwanath K. Chourasia, Amanda Fabra-García, Asier Garcia-Senosiain, Asier Garcia-Senosiain, Vandana Singh, Vandana Singh, Karin Lövgren Bengtsson, Jenny M. Reimer, Robert Sauerwein, Matthijs M. Jore, Michael Theisen, Michael Theisen

    Published 2021-01-01
    Get full text
    Article
  6. 6
    SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

    SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice by Jing-Hui Tian, Nita Patel, Robert Haupt, Haixia Zhou, Stuart Weston, Holly Hammond, James Logue, Alyse D. Portnoff, James Norton, Mimi Guebre-Xabier, Bin Zhou, Kelsey Jacobson, Sonia Maciejewski, Rafia Khatoon, Malgorzata Wisniewska, Will Moffitt, Stefanie Kluepfel-Stahl, Betty Ekechukwu, James Papin, Sarathi Boddapati, C. Jason Wong, Pedro A. Piedra, Matthew B. Frieman, Michael J. Massare, Louis Fries, Karin Lövgren Bengtsson, Linda Stertman, Larry Ellingsworth, Gregory Glenn, Gale Smith

    Published 2021-01-01
    Get full text
    Article

Search Tools: